Back
Snap- Ordinary Shares - Class A Vs. BridgeBio Pharma Industry Stock Comparison
Sell
37
SNAP
Snap- Ordinary Shares - Class A
Last Price:
$7.08
Seasonality Move:
4.8%
Sell
50
BBIO
BridgeBio Pharma
Last Price:
$51.17
Seasonality Move:
5.92%
Sell
37
Snap- Ordinary Shares - Class A (SNAP)
is a Sell
Is Snap- Ordinary Shares - Class A a Buy, Sell or Hold?
-
The current Snap- Ordinary Shares - Class A [SNAP] share price is $7.08. The Score for SNAP is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
SNAP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
BridgeBio Pharma (BBIO)
is a Sell
Is BridgeBio Pharma a Buy, Sell or Hold?
-
The current BridgeBio Pharma [BBIO] share price is $51.18. The Score for BBIO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
BBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SNAP Stock Price Chart
What is Snap- Ordinary Shares - Class A's stock price today?
-
The Snap- Ordinary Shares - Class A share price today is $7.08The current trend is moderately bullish and SNAP is experiencing selling pressure, which indicates risk of future bearish movement.
BBIO Stock Price Chart
What is BridgeBio Pharma's stock price today?
-
The BridgeBio Pharma share price today is $51.18Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing slight buying pressure.
SNAP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.8 | Buy |
Relative Strength Index (14 RSI): | 28.24 | Sell |
Chaikin Money Flow: | -47943902 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.93 - 10.05) | Sell |
Bollinger Bands (100): | (7.87 - 9.33) | Sell |
BBIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.43 | Buy |
Relative Strength Index (14 RSI): | 67.98 | Buy |
Chaikin Money Flow: | 720387 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.59 - 48.59) | Buy |
Bollinger Bands (100): | (33.94 - 45.2) | Buy |
SNAP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.62 | Sell |
20-day SMA: | 8.85 | Sell |
50-day SMA: | 8.78 | Sell |
200-day SMA: | 9.81 | Sell |
8-day EMA: | 7.28 | Sell |
20-day EMA: | 5.79 | Buy |
50-day EMA: | 3.3 | Buy |
200-day EMA: | 1 | Buy |
BBIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 48.18 | Buy |
20-day SMA: | 47.12 | Buy |
50-day SMA: | 44.51 | Buy |
200-day SMA: | 34.73 | Buy |
8-day EMA: | 48.78 | Buy |
20-day EMA: | 47.35 | Buy |
50-day EMA: | 44.46 | Buy |
200-day EMA: | 36.78 | Buy |
Snap- Ordinary Shares - Class A Earnings Growth & SNAP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.04 per share, an increase this year of $0.01 per share, and an increase next year of $0.12 per share.
BridgeBio Pharma Earnings Growth & BBIO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.29 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.20 per share, and an increase next year of $1.02 per share.
Snap- Ordinary Shares - Class A Technical Analysis
Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
BridgeBio Pharma Technical Analysis
Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | Aug 11 | Aug 12 | Aug 13 | Aug 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |